SevenBridge Financial Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-471
Closed -$79K 641
2019
Q2
$79K Sell
471
-31
-6% -$4.29K 0.03% 224
2019
Q1
$73K Hold
502
0.03% 206
2018
Q4
$67K Sell
502
-120
-19% -$19.7K 0.04% 183
2018
Q3
$119K Sell
622
-25
-4% -$4.59K 0.06% 161
2018
Q2
$108K Sell
647
-33
-5% -$5.3K 0.06% 176
2018
Q1
$114K Buy
680
+253
+59% +$42.4K 0.07% 175
2017
Q4
$70K Hold
427
0.04% 219
2017
Q3
$88K Sell
427
-77
-15% -$17.9K 0.05% 194
2017
Q2
$123K Buy
504
+75
+17% +$17.6K 0.08% 170
2017
Q1
$102K Sell
429
-233
-35% -$54.3K 0.07% 174
2016
Q4
$154K Hold
662
0.11% 150
2016
Q3
$154K Sell
662
-49
-7% -$12K 0.11% 149
2016
Q2
$164K Sell
711
-25,288
-97% -$5.83M 0.11% 153
2016
Q1
$97K Buy
+25,999
New +$7.44M 0.01% 84

Other funds holding AGN

SevenBridge Financial Group's AGN Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 471 shares — an estimated $79K sold.

SevenBridge Financial Group first reported a position in AGN in Q1 2016 and held it in 14 quarters. The position peaked at $164K in Q2 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • SevenBridge Financial Group reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • SevenBridge Financial Group sold 471 Allergan plc shares in Q3 2019, an estimated $79K.
  • SevenBridge Financial Group first reported a position in Allergan plc in Q1 2016 and held it in 14 quarters.
  • SevenBridge Financial Group's Allergan plc position peaked at $164K in Q2 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.